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Abstract: The enantioselective synthesis of the title compound, using Meyers' bicyclic 
lactam methodology, is described. This compound and a few of its derivatives are useful 
intermediates in natural product synthesis. 
 
Keywords: Asymmetric synthesis, Meyers' bicyclic lactam template, hydrindenones. 
 
 
Introduction 
 
In the context of the development of structural analogs of calcitriol, the hormonally active 
metabolite of vitamin D3 [1], we required the cis-fused perhydrindanone 7 (Scheme 1) [2]. We herein 
describe in detail the enantioselective synthesis of the potentially useful dione 5 and its further 
conversion to 7. 
 
Results and Discussion 
 
The synthesis of 7, a cis-fused angularly substituted perhydrindane dione, in which one of the 
carbonyl groups is protected as cyclic ketal, involves two phases. First Meyers' methodology for the 
enantioselective synthesis of hydrindenones is applied in the preparation of 5 [3]. In a second phase, 
the cyclohexanone carbonyl group of 5 is protected as an ethylene ketal and the cis-fusion in 7 is 
obtained by stereoselective catalytic hydrogenation of 6. Molecules 2006, 11   
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Meyers' approach for the asymmetric synthesis of angularly substituted hydrinden-2-ones proceeds 
in 3 stages: (i) the asymmetric introduction of the quaternary center using a chiral bicyclic lactam such 
as  1; (ii) the reductive intramolecular alkylation in which the 1,4-diketone is generated; (iii) the 
intramolecular aldolisation of the latter to the hydrinden-2-one. We chose to introduce the second 
carbonyl group in 5 via oxidative cleavage of the exocyclic double bond in 4. Following Meyers' 
methodology the latter is obtained from diastereomer 2a. 
To stereoselectively obtain the correct configuration at the 6-position in 2a, the methyl group and 
the unsaturated side chain need to be introduced sequentially and in that precise order. Indeed, the 
prior introduction of the unsaturated side chain could eventually lead to the formation of spirocyclic 
derivatives [4]. On the other hand, the preferred endo-alkylation of Meyers' bicyclic lactam template 
has been well documented [5]. Hence, enantiomerically pure (+)-1 was required as starting material [6]. 
Scheme 1. Synthetic pathway to tetrahydro-1H-inden-2,6-dione 5 and derivatives. 
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(a) (i) LDA, THF, –78 °C; (ii) MeI, –78 °C, 2 h (96%); (b) (i) LDA, DMPU, THF, –78 °C;   
(ii)  8, –78 °C; 3 h (84%); (c) t-BuLi, KH, THF, –78 °C, 45 min; (d) n-Bu4NH2PO4, EtOH,   
75 °C, 12 h (68% from 2a); (e) KOH, EtOH, rt, 16 h (89%); (f) O3, CH2Cl2, –78 °C (73%); (g) 
HO(CH2)2OH, TsOH, toluene, reflux, 2 h (92%); (h) H2, Pd/C, EtOAc, rt, 2.5 h (100%). 
The methylation of 1 led to a 9:1 diastereomeric mixture, which was not separated. After further 
deprotonation with LDA (DMPU, THF) and alkylation with the known dibromide 8 [7], a 7:3 mixture 
of 2a and 2b was obtained, which was separated by chromatography. The preferred formation of the 
endo-isomer 2a was proven by 
1H-NMR nOe signal-enhancement studies establishing the relative 
positions of the Me groups and H atoms indicated in Figure 1. The major isomer 2a was subjected to Molecules 2006, 11   
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Meyers' protocol (KH, t-BuLi) yielding diketone 3. Basic treatment (KOH, EtOH) led to hydrinden-2-
one 4. Selective cleavage of the exocyclic double bond in 4 (ozone, Me2S) gave diketone 5 in which 
the saturated carbonyl group was further protected to afford the ketal 6. Finally, catalytic 
hydrogenation of the latter occurred exclusively from the convex side of the bicyclic molecule leading 
to the cis-fused perhydrindanone 7, the structure of which was confirmed by 
1H-NMR structural 
analysis: upon irradiation of the angular Me group a clear nOe enhancement of the signal of the 
bridgehead hydrogen was observed, confirming the cis-fusion of the hydrindane (Figure 1). 
Figure 1. 
1H-NMR nOe signal-enhancement studies of 2a and 7. 
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Conclusions 
 
Angularly substituted perhydrindanones are useful intermediates in synthesis. The asymmetric 
synthesis of 7, in which an additional carbonyl group in protected ketal form is present (overall yield 
33%), following a sequence of 7 steps starting from commercially available (+)-1 provides a useful 
example of the general applicability of Meyers' methodology. 
 
Experimental 
 
General 
 
Tetrahydrofuran (THF) was distilled from benzophenone ketyl. Dichloromethane (DCM) was 
distilled from CaH2. Toluene was distilled from sodium. TLC were run on glass plates precoated with 
silica gel (Merck, 60F-254). Column chromatography was performed on silica gel (Merck, 230-400 
mesh). IR spectra were recorded on a Perkin–Elmer series 1600 FT-IR spectrometer. 
1H-NMR and 
13C-NMR spectra were recorded on a Bruker AM-500 spectrometer. Hydrogen chemical shifts δ are 
reported in ppm relative to CDCl3 (7.26 ppm) as an internal reference. J values are given in Hz. 
Carbon chemical shifts δ are reported in ppm relative to CDCl3 (77.16 ppm) as an internal reference. 
Mass spectra (EI) were recorded on a Hewlett–Packard 5898A spectrometer at 70 eV. 
 
(3S,6S,7aR)-6-[2-(2-Bromoethyl)-3-methylbut-2-en-1-yl]-3-isopropyl-6,7a-dimethyltetrahydro-
pyrrolo[2,1-b][1,3]oxazol-5(6H)-one ((+)-2a) [8] 
To i-Pr2NLi (LDA, 2 M solution in THF; 110 mL, 0.22 mol) was added dry THF (1100 mL) and 
the solution was cooled to –78 °C. (3S,7aR)-3-Isopropyl-7a-methyltetrahydropyrrolo[2,1-b][1,3]-
oxazol-5(6H)-one ((+)-1; 20 g, 0.11 mol) was added dropwise and the mixture was stirred for 30 min. 
MeI (46.74 g, 20.5 mL, 0.33 mol) was then added dropwise, the reaction mixture was stirred for 2 h 
and then allowed to warm to rt. An aqueous saturated NH4Cl solution (50 mL) was added and the Molecules 2006, 11   
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mixture was stirred for 1 h. H2O was added, the aqueous layer was extracted with Et2O (3×), the 
combined organic layers were dried over anhydrous MgSO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography on silica gel (isooctane/EtOAc, 7:3) to afford a 
9:1 mixture of the (6R/6S)-diastereomers of the methylated bicyclic lactam (20.8 g, 96%). 
To LDA (2 M solution in THF; 7.5 mL, 20 mmol) was added dry THF (100 mL) and the solution 
was cooled to –78 °C. 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU; 11 mL) was 
added and the mixture was stirred for 10 min. The above mixture of methylated bicyclic lactams (2.0 g, 
10.1 mmol) in dry THF (10 mL) was added dropwise and the reaction mixture was stirred for 2 h. 
5-Bromo-3-(bromomethyl)-2-methylpent-2-ene (8; 5.12 g, 20 mmol) in dry THF (10 mL) was then 
added dropwise and stirring was continued for 1 h. An aqueous saturated NH4Cl solution (20 mL) was 
added and the mixture was allowed to warm to rt. H2O was added, the aqueous layer was extracted 
with Et2O, the combined organic layers were dried over anhydrous MgSO4 and concentrated under 
reduced pressure. The obtained 7:3 mixture of isomers of the dialkylated bicyclic lactam (3.1 g, 84%) 
was separated by column chromatography on silica gel (isooctane/ EtOAc, 7:3) to give the major (6S)-
isomer (+)-2a as a solid: mp 45 °C; Rf (isooctane/EtOAc, 95:5) 0.22; [α]D
rt +106.5 (c 1.15, CHCl3); IR 
(KBr pellet) ν 2963, 2871, 1708, 1463, 1376, 1381, 1298, 1252, 1218, 1176, 1130, 1037, 1006), 967, 
903, 842, 808, 771, 684, 650 cm
–1; 
1H-NMR (500 MHz, CDCl3) δ 4.18 (1 H, dd, J = 8.8, 8.8 Hz), 3.77 
(1 H, dd, J = 7.9, 7.9 Hz), 3.59–3.54 (1 H, m), 3.39–3.34 (1 H, m), 3.28–3.22 (1 H, m), 2.39 (2 H, s), 
2.68–2.62 (1 H, m), 2.29–2.23 (1 H, m), 2.24 (1 H, d, J = 13.5 Hz), 1.88 (1 H, d, J = 13.3 Hz), 1.71 (3 
H, s), 1.66–1.63 (1 H, m), 1.63 (3 H, s), 1.50 (3 H, s), 1.29 (3 H, s), 1.04 (3 H, d, J = 6.6 Hz), 0.88 (3 H, 
d, J = 6.6 Hz) ppm; 
13C-NMR/DEPT (50 MHz, CDCl3) δ 183.7 (C), 132.9 (C ), 126.8 (C), 96.8 (C), 
70.6 (CH2), 61.6 (CH), 48.3 (C), 45.5 (CH2), 38.2 (CH2), 35.6 (CH2), 34.2 (CH), 30.9 (CH2), 27.5 
(CH3), 25.8 (CH3), 21.4 (CH3), 20.7 (CH3), 20.6 (CH3), 18.9 (CH3) ppm; MS m/z (%) 372 (M
+, 17), 
359 (17), 358 (88), 357 (20), 356 (88), 341 (14), 331 (11), 330 (60), 328 (100), 326 (46), 310 (7), 300 
(21). Anal. Calcd for C18H30BrNO2: C, 58.10; H, 8.06; N, 3.76. Found: C, 57.95; H, 8.25, N, 3.70. 
 
(2S)-2-Methyl-4-(1-methylethylidene)-2-(2-oxopropyl)cyclohexanone ((+)-3) 
To a solution of dialkylated bicyclic lactam (+)-2a (1.0 g, 2.7 mmol) in dry THF (54 mL) were 
added t-BuLi (1.7 M solution in pentane; 3.32 mL, 5.6 mmol) and KH (0.324 g, 8.1 mmol) at –78 °C 
and the reaction mixture was stirred for 45 min. H2O (20 mL) was added and the mixture was allowed 
to warm to rt under stirring for 20 min. The solution was concentrated under reduced pressure to 1/3 of 
its volume and EtOH (20 mL) was added to obtain a homogeneous solution. A 1 M n-Bu4NH2PO4 
solution (26.5 mL, 0.081 mmol) was added and the mixture was refluxed for 12 h. After cooling, H2O 
was added, the aqueous layer was extracted with Et2O (2×), the combined organic layers were dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (isooctane/EtOAc, 8:2) to give diketone (+)-3 (0.388 g, 68%): Rf 
(isooctane/EtOAc, 8:2) 0.33; [α]D
rt +20.5 (c 1.10, CHCl3); IR (KBr film) ν 2963, 2921, 1710, 1456, 
1360, 1167, 1104 cm
–1; 
1H-NMR (500 MHz, CDCl3) δ 2.98 (1 H, AB, J = 17.7 Hz), 2.69–2.63 (2 H, 
m), 2.56–2.47 (2 H, m), 2.49 (1 H, AB, J = 17.7 Hz), 2.44–2.38 (1 H, m), 2.34 (1 H, d, J = 14.1 Hz), 
2.10 (3 H, s), 1.71 (3 H, s), 1.70 (3 H, s), 1.03 (3 H, s) ppm; 
13C-NMR/APT (125 MHz, CDCl3) δ 
206.9 (C), 206.9 (C), 126.1 (C), 125.3 (C), 52.2 (CH2), 47.0 (C), 38.6 (CH2), 38.6 (CH2), 30.7 (CH3), 
27.2 (CH2), 24.1 (CH3), 20.4 (CH3), 20.3 (CH3); MS m/z (%) 208 (M
+, 1), 150 (49), 135 (34), 107 (43), Molecules 2006, 11   
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93 (21), 79 (26), 67 (21), 43 (100). 
 
(7aS)-7a-Methyl-6-(1-methylethylidene)-1,4,5,6,7,7a-hexahydro-2H-inden-2-one ((+)-4) 
To a solution of diketone (+)-3 (2.5 g, 12 mmol) in EtOH (12 mL) was added KOH (0.64 g, 12 
mmol) and the reaction mixture was stirred at rt for 16 h. H2O was added and the aqueous layer was 
extracted with Et2O (3×). The combined organic layers were washed with a saturated NaCl solution, 
dried over anhydrous MgSO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (isooctane/EtOAc, 9:1) to give enone (+)-4 (2.0 g, 89%) as 
yellow crystals: mp 84 °C; Rf (isooctane/EtOAc, 8:2) 0.37; [α]D
rt +53.15 (c 0.75, CHCl3); IR (KBr film) 
ν 2956, 2916, 2860, 2358, 1709, 1620, 1437, 1409, 1372, 1274, 1220, 1171, 840, 750, 670 cm
–1; 
1H-
NMR (500 MHz, CDCl3) δ 5.79 (1 H, d, J = 1.6 Hz), 2.96 (1 H, m), 2.89 (1 H, dd, J = 13.0, 2.3 Hz), 
2.72 (1 H, ddd, J = 13.6, 4.6, 2.3 Hz), 2.36 (1 H, ddd, J = 13.5, 13.5, 6.3 Hz), 2.33 (1 H, AB, J = 18.4 
Hz), 2.28 (1 H, AB, J = 18.4 Hz), 1.82–1.75 (2 H, m), 1.77 (3 H, s), 1.72 (3 H, s), 1.13 (3H, s) ppm; 
13C-NMR/APT (125 MHz, CDCl3) δ 208.2 (C), 188.0 (C), 126.8 (C), 126.2 (C), 126.0 (CH), 51.1 
(CH2), 45.2 (C), 43.9 (CH2), 30.6 (CH2), 28.9 (CH2), 24.2 (CH3), 20.5 (CH3), 20.4 (CH3) ppm; MS m/z 
(%) 190 (M
+, 100), 175 (32), 162 (10), 147 (76), 133 (15), 119 (57), 105 (44), 91 (47), 79 (38), 55 (28), 
41 (45). 
 
(7aS)-7a-Methyl-4,5,7,7a-tetrahydro-1H-indene-2,6-dione ((–)-5) 
O3 was bubbled through a solution of alkene (+)-4 (0.48 g, 2.5 mmol) in DCM (126 mL) at –78 °C 
for 8 min. Me2S (0.3 mL, 3.4 mmol) was added, the reaction mixture was allowed to warm to 0 °C, 
stirred for 1 h and then allowed to warm to rt. The solvent was evaporated and the residue was purified 
by column chromatography on silica gel (Et2O/isooctane, 9:1) to give ketone (–)-5 (0.298 g, 73%): Rf 
(Et2O/isooctane, 9:1) 0.23; [α]D
rt –62.0 (c 1.10, CHCl3); IR (KBr film) ν 3070, 2953, 1710, 1678, 1622, 
1432, 1337, 1296, 1198, 1090, 1070, 902 cm
–1; 
1H-NMR (500 MHz, CDCl3) δ 6.02 (1 H, d, J = 1.7 
Hz), 3.06 (1 H, ddd, J = 14.6, 7.5, 1.4 Hz), 2.83 (1 H, dddd, J = 14.6, 13.1, 6.7, 1.7 Hz), 2.67–2.61 (2 
H, m), 2.52–2.44 (2 H, m), 2.43 (1 H, AB, J = 18.6 Hz), 2.39 (1 H, AB, J = 18.6 Hz), 1.25 (3 H, s) 
ppm; 
13C-NMR/APT (125 MHz, CDCl3) δ 207.2 (C), 206.4 (C), 181.2 (C), 128.3 (C), 54.2 CH2), 51.2 
(CH2), 45.4 CH), 40.0 (CH2), 26.09 (CH2), 25.5 (CH3) ppm; MS m/z (%) 164 (M
+, 86), 149 (18), 136 
(14), 121 (39), 107 (44), 93 (56), 79 (100), 55 (25), 53 (30). 
 
(3a'S)-3a'-Methyl-3a',4',6',7'-tetrahydrospiro[1,3-dioxolane-2,5'-inden]-2'(3'H)-one ((+)-6) 
To a solution of ketone (–)-5 (0.77 g, 4.7 mmol) in dry toluene (47 mL) were added 
HOCH2CH2OH (0.3 g, 0.27 mL, 4.7 mmol) and TsOH (90 mg, 0.47 mmol). The reaction mixture was 
refluxed for 2 h with azeotropic removal of the generated H2O (Dean–Stark). The solution was allowed 
to cool, concentrated under reduced pressure and an aqueous saturated NaHCO3 solution (10 mL) was 
added. The aqueous layer was extracted with Et2O (3 × 20 mL), the combined organic layers were 
dried over anhydrous MgSO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (Et2O/isooctane, 9:1) to give ketal (+)-6 (0.9 g, 92%) as white-
yellow crystals: mp 72 °C; Rf (Et2O/isooctane, 9:1) 0.46; [α]D
rt +6.28 (c 1.03, CHCl3); IR (KBr pellet) Molecules 2006, 11   
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ν 2989, 2965, 2925, 1707, 1621, 1448, 1363, 1290, 1262, 1181, 1105, 1069, 1010, 952, 934, 907), 866, 
844, 716 cm
–1; 
1H-NMR (500 MHz, CDCl3) δ 5.83 (1 H, s), 4.05–4.00 (2 H, m), 3.92 (2 H, t, J = 6.09 
Hz), 2.69 (2 H, dd, J = 8.8, 3.2 Hz), 2.31 (1 H, AB, J = 18.3 Hz), 2.24 (1 H, AB, J = 18.3 Hz), 2.07–
2.00 (2 H, m), 1.70–1.62 (2 H, m), 1.37 (3 H, s) ppm; 
13C-NMR/APT (125 MHz, CDCl3) δ 185.97 (C), 
126.8 (CH), 107.9 (C), 107.9 (C), 64.9 (CH2), 64.0 (CH2), 53.3 (CH2), 47.3 (CH2), 43.5 (C), 35.7 
(CH2), 26.3 (CH3), 25.2 (CH2) ppm; MS m/z (%) 208 (M
+, 26), 193 (34), 152 (13), 121 (13), 107 (26), 
86 (100), 79 (35), 55 (18), 53 (21). Anal. Calcd for C12H16O3: C, 69.21; H, 7.74. Found: C, 68.86; H, 
7.95. 
 
(3a'S,7a'R)-3a'-Methylhexahydrospiro[1,3-dioxolane-2,5'-inden]-2'(3'H)-one ((+)-7) 
To a solution of enone (+)-6 (1.0 g, 4.8 mmol) in EtOAc (96 mL) was added Pd/C (10%; 0.5 g, 0.48 
mmol) and the reaction mixture was shaken under 4 bar H2 pressure (Parr apparatus) at rt for 2.5 h. 
The mixture was filtered through Celite® and the solvent was evaporated under reduced pressure to 
afford saturated ketone (+)-7 (1.0 g, 100%): Rf (isooctane/EtOAc, 9:1) 0.09; [α]D
rt +43.4 (c 1.5, 
CHCl3); IR (KBr film) ν 2931, 2884, 2250, 1736, 1453, 1407, 1364, 1256, 1211, 1145, 1098, 1068, 
1018, 994, 911, 732, 648, 608 cm
–1; 
1H NMR (500 MHz, CDCl3) δ 3.93–3.90 (4 H, m), 2.73 (1 H, AB, 
J = 18.4 Hz), 2.47 (1 H, dd, J = 18.8, 7.7 Hz), 2.04 (1 H, dd, J = 18.8, 4.2 Hz), 1.95–1.93 (1 H, m), 
1.87 (1 H, AB, J = 18.4 Hz), 1.85–1.80 (1 H, m), 1.71–1.66 (2 H, m), 1.59–1.48 (3 H, m), 1.12 (3 H, s) 
ppm; 
13C NMR/APT (125 MHz, CDCl3) δ 219.4 (C), 108.4 (C), 64.2 (CH2), 63.9 (CH2), 49.9 (CH2), 
43.0 (CH2), 42.0 (CH2), 40.8 (CH), 39.7 (CH2), 32.0 (C), 28.8 (CH3), 26.0 (CH2) ppm; MS m/z (%) 
210 (M
+, 3), 153 (9), 126 (28), 99 (100), 86 (30), 55 (18), 42 (15). 
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